SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hong Kong Cancer Registry. Cancer incidence and mortality in Hong Kong. Hong Kong: Hong Kong Cancer Registry, Hospital Authority, 2000: 3839.
  • 2
    Geara FB, Sanguineti G, Tucker SL, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol. 1997; 43: 5361.
  • 3
    Sanguineti G, Geara F, Garden A, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys. 1997; 37: 985996.
  • 4
    Ho JHC. Nasopharynx. In: HalnanKE, editor. Treatment of cancer, 1st ed. London: Chapman and Hall, 1982: 249267.
  • 5
    Cooper JS, Fu K, Marks J, et al. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys. 1995; 31: 11411164.
  • 6
    Pow EH, McMillan AS, Leung WK, et al. Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma. Clin Oral Invest. 2003; 7: 230234.
  • 7
    Schwarz E, Chiu GK, Leung WK. Oral health status of southern Chinese following head and neck irradiation therapy for nasopharyngeal carcinoma. J Dentistry. 1999; 27: 2128.
  • 8
    Pow E, McMillan AS, Leung WK, et al. Oral health condition in southern Chinese after radiotherapy for nasopharyngeal carcinoma: extent and nature of the problem. Oral Dis. 2003; 9: 196202.
  • 9
    Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal cancer. Head Neck. 2000; 22: 393397.
  • 10
    Wu QW, Mohan R, Morris M, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. 1: dosimetric results. Int J Radiat Oncol Biol Phys. 2003; 56: 573585.
  • 11
    Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003; 56: 145157.
  • 12
    Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001; 50: 695704.
  • 13
    Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg. 2003; 27: 832837.
  • 14
    FlemingID, CooperJS, HensenDE, et al., editors. AJCC cancer staging manual, 5th ed. Chapter 4: pharynx (including base of tongue, soft palate, and uvula). Philadelphia: Lippincott-Raven, 1998: 3338.
  • 15
    Som PM, Curtin HD, Mancuso AA. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999; 125: 388396.
  • 16
    ChaoKSC, OzyigitG, editors. Intensity modulated radiation therapy for head and neck cancer. Chapter 4: dose prescription and target delineation for nodal volume. Philadelphia: Lippincott, 2003: 3849.
  • 17
    Webb S. Inverse planning for IMRT: the role of simulated annealing. In: SternickES, editor. The theory and practice of intensity modulated radiation therapy. Proceedings of the first NOMOS IMRT workshop, Durango, Colorado. Madison: Advanced Medical Publishing, 1997: 5173.
  • 18
    Curran B. Conformal radiation therapy using a multileaf intensity modulating collimator. In: SternickES, editor. The theory and practice of intensity modulated radiation therapy. Proceedings of the first NOMOS IMRT workshop, Durango, Colorado. Madison: Advanced Medical Publishing, 1997: 7590.
  • 19
    Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [editorial]. Int J Radiat Oncol Biol Phys. 1995; 31: 13411346.
  • 20
    Baum BJ. Evaluation of stimulated parotid saliva flow rate in different age groups. J Dent Res. 1981; 60: 12921296.
  • 21
    Eisbruch A, Ten-Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999; 45: 577587.
  • 22
    Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002; 53: 1222.
  • 23
    Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001; 49: 907916.